机译:Elvitegravir / Cobicistat孕妇和产后妇女的药代动力学
Univ Calif San Diego Skaggs Sch Pharm &
Pharmaceut Sci 9500 Gilman Dr MC 0657 La Jolla CA 92093;
Univ Calif San Diego Skaggs Sch Pharm &
Pharmaceut Sci 9500 Gilman Dr MC 0657 La Jolla CA 92093;
Harvard TH Chan Sch Publ Hlth Ctr Biostat AIDS Res Boston MA USA;
Univ Calif San Diego Skaggs Sch Pharm &
Pharmaceut Sci 9500 Gilman Dr MC 0657 La Jolla CA 92093;
Univ Southern Calif Sch Med Los Angeles CA USA;
Univ Colorado Childrens Hosp Colorado Aurora CO USA;
Emory Univ Sch Med Atlanta GA USA;
Univ Alabama Birmingham Birmingham AL USA;
Icahn Sch Med Mt Sinai Bronx Lebanon Hosp Ctr New York NY 10029 USA;
NIAID Maternal Adolescent &
Pediat Res Branch 9000 Rockville Pike Bethesda MD 20892 USA;
Eunice Kennedy Shriver Natl Inst Child Hlth &
Hum Maternal &
Pediat Infect Dis Branch Bethesda;
Univ Calif San Diego Skaggs Sch Pharm &
Pharmaceut Sci 9500 Gilman Dr MC 0657 La Jolla CA 92093;
Childrens Hosp Boston Boston MA USA;
Harvard TH Chan Sch Publ Hlth Ctr Biostat AIDS Res Boston MA USA;
Boston Univ Sch Med Boston MA 02118 USA;
cobicistat; elvitegravir; HIV infection; integrase inhibitor; perinatal transmission; pharmacokinetics; pregnancy;
机译:Elvitegravir / Cobicistat孕妇和产后妇女的药代动力学
机译:整合酶抑制剂Elvitegravir和艾滋病毒孕妇中的药代动力学和安全性
机译:孕妇和产后妇女的Dolutegrivir药代动力学与艾滋病毒一起生活
机译:新的食品支持效益对英国谢菲尔德股市孕妇饮食行为的影响
机译:孕妇和产后妇女的医疗保健患有物质使用障碍
机译:Dolutegravir在感染HIV的孕妇和产后妇女中的药代动力学
机译:患有人免疫缺陷病毒的怀孕患者的第三个三个月期间临床显着的较低elvitegravir暴露:艾滋病毒感染妇女(PANNA)网络中抗逆转录病毒剂的药代动力学数据